Moderna (MRNA) Earnings Recap for Q3 2024: Revenue & EPS Beat Expectations
Welcome to Earnings Central! In this video, we break down Moderna’s Q3 2024 earnings report, where the company exceeded expectations with $1.86 billion in revenue, up 48.95% over estimates, and reported a profit of $0.03 per share, a dramatic increase from last year. We’ll cover key financial metrics like Moderna’s impressive cost savings, their reduced R&D and SG&A expenses, and significant progress in pipeline growth, including vaccines for COVID, RSV, and flu. Plus, learn about Moderna’s strategic moves for international expansion and leadership development. Stay tuned for a quick and insightful recap!
#Moderna #EarningsReport #BiotechNews #Q32024 #EarningsCentral